| Ticker | KURA |
|---|---|
| ISIN | US50127T1097 |
| Sector | Atención sanitaria |
| Mercado | NASDAQ |
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A protein-protein interaction for the treatment of genetically defined subsets of acute leukemias, including acute myeloid leukemia and acute lymphoblast...
El precio actual de Kura Oncology, Inc. (KURA) es de 9,25 , con una variación del -0,16%.
Kura Oncology, Inc. opera en el sector Healthcare, industria Biotechnology.
Compara brokers con acceso a las principales bolsas internacionales, con bajas comisiones, custodia y herramientas de análisis para invertir en acciones.
Compara brokers para acciones